A carregar...
Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms
The introduction of immunosuppressant belatacept, an inhibitor of the CD28-80/86 pathway, has improved 1-year outcomes in kidney transplant recipients with preexistent diabetes mellitus and has also reduced the risk of posttransplant diabetes mellitus. So far, no studies have compared a tacrolimus-b...
Na minha lista:
| Publicado no: | Transplant Direct |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5912016/ https://ncbi.nlm.nih.gov/pubmed/29707621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000767 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|